Green Thumb Industries (GTBIF) Depreciation and Depletion (2019 - 2026)
Green Thumb Industries (GTBIF) posted Depreciation and Depletion of $20.7 million for Q1 2026, down 52.56% on a QoQ basis from $43.7 million in Q4 2025, and up 23.12% year-over-year from $16.8 million in Q1 2025.
Green Thumb Industries (GTBIF) Depreciation and Depletion (2019 - 2026) Analysis & Trends
Green Thumb Industries' Depreciation and Depletion history runs 8 years deep, the most recent figure standing at $20.7 million for Q1 2026.
- Quarterly Depreciation and Depletion rose 23.12% year-over-year to $20.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.4 million (up 54.04% YoY) and the FY2025 annual result came in at $95.5 million, up 52.09% from the prior year.
- Depreciation and Depletion was $20.7 million for Q1 2026 at Green Thumb Industries, down from $43.7 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $43.7 million in Q4 2025 and bottomed at $8.0 million in Q1 2022.
- A 5-year average of $15.6 million and a median of $15.1 million in 2024 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 166.67% in 2025, while the deepest fall reached 11.47% in 2025.
- Green Thumb Industries' Depreciation and Depletion stood at $10.2 million in 2022, then soared by 44.49% to $14.7 million in 2023, then advanced by 11.59% to $16.4 million in 2024, then surged by 166.67% to $43.7 million in 2025, then tumbled by 52.56% to $20.7 million in 2026.
- Business Quant data shows GTBIF's Depreciation and Depletion at $20.7 million in Q1 2026, $43.7 million in Q4 2025, and $17.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 32.71 Bn | 30.77 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.62 Bn | 23.56 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | 21.60 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Green Thumb Industries | 1.62 Bn | 1.27 Bn | 143.65 Mn | 20.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.73 Mn |
| Mar 31, 2026 | 20.73 Mn |
| Dec 31, 2025 | 43.69 Mn |
| Dec 31, 2025 | 43.69 Mn |
| Sep 30, 2025 | 17.78 Mn |
| Sep 30, 2025 | 17.78 Mn |
| Jun 30, 2025 | 17.23 Mn |
| Jun 30, 2025 | 17.23 Mn |
| Mar 31, 2025 | 16.84 Mn |
| Mar 31, 2025 | 16.84 Mn |
| Dec 31, 2024 | 16.39 Mn |
| Dec 31, 2024 | 16.39 Mn |
| Sep 30, 2024 | 15.92 Mn |
| Sep 30, 2024 | 15.92 Mn |
| Jun 30, 2024 | 15.41 Mn |
| Jun 30, 2024 | 15.41 Mn |
| Mar 31, 2024 | 15.10 Mn |
| Mar 31, 2024 | 15.10 Mn |
| Dec 31, 2023 | 14.68 Mn |
| Dec 31, 2023 | 14.68 Mn |